Dr. Linda Jaber is a Professor of Pharmacy Practice at Wayne State University Eugene Applebaum College of Pharmacy and Health Sciences. Dr. Jaber is a national expert in diabetes treatment. Her research program initially focused on determining response differences to chronic hypoglycemic agents in patients with type 2 diabetes. This research evaluated the effects of chronic dosing, age, and obesity on the pharmacokinetics and pharmacodynamics of hypoglycemic agents. Her studies of the Arab Americans provided the first representative, population-based, cross-sectional prevalence estimates of diabetes, pre-diabetes, and the metabolic syndrome as well as the risk factors underlying the progression to diabetes. Her research led to the characterization of the metabolic defects underlying the progression to diabetes, the association between Vitamin D and Insulin resistance, and exploring the racial differences in sensitivity and specificity of glycated hemoglobin in identifying diabetes and pre-diabetes in this population. Her research also included examining the feasibility of a culturally adapted diabetes prevention model in this ethnic group.